|
1
|
Burger M, Catto JW, Dalbagni G, Grossman
HB, Herr H, Karakiewicz P, Kassouf W, Kiemeney LA, La Vecchia C,
Shariat S and Lotan Y: Epidemiology and risk factors of urothelial
bladder cancer. Eur Urol. 63:234–241. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mahdavifar N, Ghoncheh M, Pakzad R,
Momenimovahed Z and Salehiniya H: Epidemiology, incidence and
mortality of bladder cancer and their relationship with the
development index in the world. Asian Pac J Cancer Prev.
17:381–386. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li S, Zeng XT, Ruan XL, Wang XH, Guo Y and
Yang ZH: Simultaneous transurethral resection of bladder cancer and
prostate may reduce recurrence rates: A systematic review and
meta-analysis. Exp Ther Med. 4:685–692. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Vinall RL, Tepper CG, Ripoll AA,
Gandour-Edwards RF, Durbin-Johnson BP, Yap SA, Ghosh PM and deVere
White RW: Decreased expression of let-7c is associated with
non-response of muscle-invasive bladder cancer patients to
neoadjuvant chemotherapy. Genes Cancer. 7:86–97. 2016.PubMed/NCBI
|
|
6
|
Cirone P, Andresen CJ, Eswaraka JR, Lappin
PB and Bagi CM: Patient-derived xenografts reveal limits to
PI3K/mTOR-and MEK-mediated inhibition of bladder cancer. Cancer
Chemother Pharmacol. 73:525–538. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang Y, Leng H, Chen H, Wang L, Jiang N,
Huo X and Yu B: Knockdown of UBE2T inhibits osteosarcoma cell
proliferation, migration, and invasion by suppressing the PI3K/Akt
signaling pathway. Oncol Res. 24:361–369. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dong Q, Fu L, Zhao Y, Tan S and Wang E:
Derlin-1 overexpression confers poor prognosis in muscle invasive
bladder cancer and contributes to chemoresistance and invasion
through PI3K/AKT and ERK/MMP signaling. Oncotarget. 8:17059–17069.
2017.PubMed/NCBI
|
|
9
|
Alayev A, Salamon RS, Schwartz NS, Berman
AY, Wiener SL and Holz MK: Combination of rapamycin and resveratrol
for treatment of bladder cancer. J Cell Physiol. 232:436–446. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nam KN, Choi YS, Jung HJ, Park GH, Park
JM, Moon SK, Cho KH, Kang C, Kang I, Oh MS and Lee EH: Genipin
inhibits the inflammatory response of rat brain microglial cells.
Int Immunopharmacol. 10:493–499. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang GF, Wu SY, Rao JJ, Lü L, Xu W, Pang
JX, Liu ZQ, Wu SG and Zhang JJ: Genipin inhibits endothelial
exocytosis via nitric oxide in cultured human umbilical vein
endothelial cells. Acta Pharmacol Sin. 30:589–596. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang CY, Parton LE, Ye CP, Krauss S, Shen
R, Lin CT, Porco JA Jr and Lowell BB: Genipin inhibits
UCP2-mediated proton leak and acutely reverses obesity- and high
glucose-induced beta cell dysfunction in isolated pancreatic
islets. Cell Metab. 3:417–427. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Suzuki Y, Kondo K, Ikeda Y and Umemura K:
Antithrombotic effect of geniposide and genipin in the mouse
thrombosis model. Planta Med. 67:807–810. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hughes RH, Silva VA, Ahmed I, Shreiber DI
and Morrison B III: Neuroprotection by genipin against reactive
oxygen and reactive nitrogen species-mediated injury in organotypic
hippocampal slice cultures. Brain Res. 1543:308–314. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang N, Zhu M, Tsao SW, Man K, Zhang Z and
Feng Y: Up-regulation of TIMP-1 by genipin inhibits MMP-2
activities and suppresses the metastatic potential of human
hepatocellular carcinoma. PLoS One. 7:e463182012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang R, MoYung KC, Zhao YJ and Poon K: A
mechanism for the temporal potentiation of genipin to the
cytotoxicity of cisplatin in colon cancer cells. Int J Med Sci.
13:507–516. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Perelman A, Wachtel C, Cohen M, Haupt S,
Shapiro H and Tzur A: JC-1: Alternative excitation wavelengths
facilitate mitochondrial membrane potential cytometry. Cell Death
Dis. 3:e4302012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Singh AN, Baruah MM and Sharma N:
Structure Based docking studies towards exploring potential
anti-androgen activity of selected phytochemicals against Prostate
Cancer. Sci Rep. 7:19552017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Koo HJ, Song YS, Kim HJ, Lee YH, Hong SM,
Kim SJ, Kim BC, Jin C, Lim CJ and Park EH: Antiinflammatory effects
of genipin, an active principle of gardenia. Eur J Pharmacol.
495:201–208. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cao H, Feng Q, Xu W, Li X, Kang Z, Ren Y
and Du L: Genipin induced apoptosis associated with activation of
the c-Jun NH2-terminal kinase and p53 protein in HeLa cells. Biol
Pharm Bull. 33:1343–1348. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ko H, Kim JM, Kim SJ, Shim SH, Ha CH and
Chang HI: Induction of apoptosis by genipin inhibits cell
proliferation in AGS human gastric cancer cells via Egr1/p21
signaling pathway. Bioorg Med Chem Lett. 25:4191–4196. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Feng Q, Cao HL, Xu W, Li XR, Ren YQ and Du
LF: Apoptosis induced by genipin in human leukemia K562 cells:
Involvement of c-Jun N-terminal kinase in G2/M arrest. Acta
Pharmacol Sin. 32:519–527. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Coqueret O: New roles for p21 and p27
cell-cycle inhibitors: A function for each cell compartment? Trends
Cell Biol. 13:65–70. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pastorino JG, Chen ST, Tafani M, Snyder JW
and Farber JL: The overexpression of bax produces cell death upon
induction of the mitochondrial permeability transition. J Biol
Chem. 273:7770–7775. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang X, Yao J, Luo Y, Han Y, Wang Z and Du
L: P38 MAP kinase mediates apoptosis after genipin treatment in
non-small-cell lung cancer H1299 cells via a mitochondrial
apoptotic cascade. J Pharmacol Sci. 121:272–281. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Qin J, Xie LP, Zheng XY, Wang YB, Bai Y,
Shen HF, Li LC and Dahiya R: A component of green tea,
(−)-epigallocatechin-3-gallate, promotes apoptosis in T24 human
bladder cancer cells via modulation of the PI3K/Akt pathway and
Bcl-2 family proteins. Biochem Biophys Res Commun. 354:852–857.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kim MS, Kim JE, Lim DY, Huang Z, Chen H,
Langfald A, Lubet RA, Grubbs CJ, Dong Z and Bode AM: Naproxen
induces cell-cycle arrest and apoptosis in human urinary bladder
cancer cell lines and chemically induced cancers by targeting PI3K.
Cancer Prev Res (Phila). 7:236–245. 2014. View Article : Google Scholar : PubMed/NCBI
|
